Home Research Feeds Profiling the Salivary microbiome of the Qatari population

Profiling the Salivary microbiome of the Qatari populationOriginal paper

Researched by:

  • Karen Pendergrass

Last Updated: 2026-07-04

Karen Pendergrass
Karen Pendergrass

Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.

Read More
Location
Qatar
Sample Site
Saliva
Species
Homo sapiens

What was studied?

Researchers characterized the salivary microbiome of 997 Qatari adults, one of the largest population-based studies of its kind. They examined how microbial composition relates to age, oral health, denture use, smoking, and coffee or tea consumption.

How was it studied?

Saliva samples were profiled using high-throughput sequencing of the V1-V3 region of the 16S rRNA gene.

What did they find?

Bacteroidetes, Firmicutes, Actinobacteria, and Proteobacteria were the dominant phyla, with Bacteroidetes most predominant overall and more so in males. Elderly participants showed lower microbial diversity, with Prevotella and Treponema most significant. Participants with mouth ulcers, bleeding, or painful gums showed dominant Prevotella and Capnocytophaga and reduced diversity, a pattern echoed in smokers. Denture users showed more Streptococcus and Neisseria, while frequent coffee drinkers had higher diversity and tea drinkers had higher richness.

Why it matters

This is the first study to characterize the salivary microbiome in an Arab population, linking specific taxa to age, oral disease, smoking, and beverage habits.

Join the Roundtable

Contribute to published consensus reports, connect with top clinicians and researchers, and receive exclusive invitations to roundtable conferences.

Join the Waitlist and help shape the future of microbiome medicine.